Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PubMed

Regulatory Aspects of Artificial Intelligence and Machine Learning.

PMID: 39260776 ·

L, i, r, o, n, , P, a, n, t, a, n, o, w, i, t, z, ;, , M, a, t, t, h, e, w, , H, a, n, n, a, ;, , J, o, s, h, u, a, , P, a, n, t, a, n, o, w, i, t, z, ;, , J, o, e, , L, e, n, n, e, r, z, ;, , W, a, l, t, e, r, , H, , H, e, n, r, i, c, k, s, ;, , P, e, t, e, r, , S, h, e, n, ;, , B, r, u, c, e, , Q, u, i, n, n, ;, , S, h, a, n, n, o, n, , B, e, n, n, e, t, ;, , H, o, o, m, a, n, , H, , R, a, s, h, i, d, i

RevistaModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Año
PMID39260776

Resumen

In the realm of health care, numerous generative and nongenerative artificial intelligence and machine learning (AI-ML) tools have been developed and deployed. Simultaneously, manufacturers of medical devices are leveraging AI-ML. However, the adoption of AI in health care raises several concerns, including safety, security, ethical biases, accountability, trust, economic impact, and environmental effects. Effective regulation can mitigate some of these risks, promote fairness, establish standar

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.

↑